Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thibaud Damy

Showing results (1-10 of 293) with videos related to

Pageof 30
Sort By:
Soins; La Revue De Reference Infirmiere|May 1, 2023
[The taboo of the impact of end of life and death on caregivers]Thibaud Damy
Soins; La Revue De Reference Infirmiere|November 21, 2017
[Heart failure, progress and challenges]Thibaud Damy
European Heart Journal|October 21, 2022
The challenge of managing patients with light-chain cardiac amyloidosis: the value of cardiac magnetic resonance as a guide to the treatment responseThibaud Damy, Amira Zaroui, Silvia Oghina
European Heart Journal|August 2, 2020
Aortic stenosis and amyloid heart disease: 'the 2A dangerous liaisons'Dania Mohty, Philippe Pibarot, Thibaud Damy
JACC. Cardiovascular Imaging|August 9, 2023
Reply: Deep Learning on Bone ScintigraphyMarc-Antoine Delbarre, François Girardon, Thibaud Damy
Archives of Cardiovascular Diseases|November 27, 2012
Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin geneThibaud Damy, Violaine Plante-Bordeneuve, Sophie Valleix
Archives of Cardiovascular Diseases|September 28, 2013
Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shockThibaud Damy, Violaine Plante-Bordeneuve, Ahmet Dogan
European Heart Journal|August 12, 2025
Nonagenarian patients with ATTR cardiac amyloidosis: should they be treated with tafamidis?Antoine Jobbé-Duval, Thibaud Damy, Amaury Broussier
European Journal of Heart Failure|December 19, 2020
Reply to the letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'Thibaud Damy, Marla B Sultan, Ronald Witteles
Presse Medicale (Paris, France : 1983)|July 7, 2014
[Answer to the letter from Mrs Aurélie Daumas about our article "senile systemic amyloidosis: definition, diagnosis, why thinking about?"]Jean Rosso, Arnaut Gallat, Aziz Guellich, et al.
Pageof 30

Showing results (1-10 of 293) with videos related to

Sort By:
Pageof 30
Soins; La Revue De Reference Infirmiere|May 1, 2023
[The taboo of the impact of end of life and death on caregivers]Thibaud Damy
Soins; La Revue De Reference Infirmiere|November 21, 2017
[Heart failure, progress and challenges]Thibaud Damy
European Heart Journal|October 21, 2022
The challenge of managing patients with light-chain cardiac amyloidosis: the value of cardiac magnetic resonance as a guide to the treatment responseThibaud Damy, Amira Zaroui, Silvia Oghina
European Heart Journal|August 2, 2020
Aortic stenosis and amyloid heart disease: 'the 2A dangerous liaisons'Dania Mohty, Philippe Pibarot, Thibaud Damy
JACC. Cardiovascular Imaging|August 9, 2023
Reply: Deep Learning on Bone ScintigraphyMarc-Antoine Delbarre, François Girardon, Thibaud Damy
Archives of Cardiovascular Diseases|November 27, 2012
Diagnosis of cardiac amyloidosis by magnetic resonance imaging due to a new mutation in the transthyretin geneThibaud Damy, Violaine Plante-Bordeneuve, Sophie Valleix
Archives of Cardiovascular Diseases|September 28, 2013
Characterization of untyped cardiac amyloidosis by mass spectrometry in a patient with Gly6Ser transthyretin polymorphism in fatal cardiogenic shockThibaud Damy, Violaine Plante-Bordeneuve, Ahmet Dogan
European Heart Journal|August 12, 2025
Nonagenarian patients with ATTR cardiac amyloidosis: should they be treated with tafamidis?Antoine Jobbé-Duval, Thibaud Damy, Amaury Broussier
European Journal of Heart Failure|December 19, 2020
Reply to the letter regarding the article 'Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study'Thibaud Damy, Marla B Sultan, Ronald Witteles
Presse Medicale (Paris, France : 1983)|July 7, 2014
[Answer to the letter from Mrs Aurélie Daumas about our article "senile systemic amyloidosis: definition, diagnosis, why thinking about?"]Jean Rosso, Arnaut Gallat, Aziz Guellich, et al.
Pageof 30